Dr Lal Pathlabs Ltd share price logo

Dr Lal Pathlabs Ltd Share Price

(LALPATHLAB)

₹2478.80.37%

as on 04:01PM, 28 Mar 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Dr Lal Pathlabs Ltd Performance

  • Day's Low

    Day's High

    ₹2,460
    Day's Price Range
    ₹2,505
  • 52 Week's Low

    52 Week's High

    ₹2,146
    52-Week Price Range
    ₹3,653.95
1 Month Return+ 5.49 %
3 Month Return-16.11 %
1 Year Return+ 8.33 %
Previous Close₹2,488.00
Open₹2,487.75
Volume87.65K
Upper Circuit₹2,985.60
Lower Circuit₹1,990.40
Market Cap₹20,720.72Cr

Dr Lal Pathlabs Ltd Fundamentals

P/E Ratio

49.54

PEG Ratio

4.8

Market Cap

₹20,720.72 Cr

P/B Ratio

9.94

EPS

43.4

Dividend Yield

0.8

Sector

Healthcare

ROE

21.42

Dr Lal Pathlabs Ltd Analyst Rating

based on 23 analysts

HOLD

60.87%

Buy

8.70%

Hold

30.43%

Sell

Based on 23 analysts offering long term price targets for Dr Lal Pathlabs Ltd. An average target of ₹3105.65

Source: S&P Global Market Intelligence

Dr Lal Pathlabs Ltd Share analysis

Dr Lal Pathlabs Ltd price forecast by 23 analysts

Upside of25.29%

High

₹3770

Target

₹3105.65

Low

₹2380

Dr Lal Pathlabs Ltd target price ₹3105.65, a slight upside of 25.29% compared to current price of ₹2478.8. According to 23 analysts rating.

Source: S&P Global Market Intelligence

Key events for Dr Lal Pathlabs Ltd

  • Dr. Lal PathLabs Consolidates Operations with Subsidiary Liquidation - 19 Mar, 2025

    Dr. Lal PathLabs has announced the voluntary liquidation of its subsidiary, Suburban Diagnostics, effective March 18, 2025. This consolidation aims to streamline operations and enhance market positioning, as Suburban contributed significantly to the company's turnover and net worth in the last financial year.
  • HDFC Securities Sets Target Price for Dr Lal Pathlabs - 18 Mar, 2025

    HDFC Securities has an 'add' call on Dr Lal Pathlabs with a target price of Rs 2,910, reflecting a 10% discount to its long-term PE average. The company reported a consolidated total income of Rs 621.80 crore for Q4 FY24, down 8.84% from the previous quarter but up 11.59% year-on-year. Promoters hold 53.91% stake, while FIIs and DIIs own 26.82% and 12.87%, respectively.

Insights on Dr Lal Pathlabs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 9.84% to 10.25% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Fortis Healthcare Ltd has given 62.8% return, outperforming this stock by 54.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 208.6% return, outperforming this stock by 213.8%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 26.82% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 682.1 Cr → 621.8 Cr (in ₹), with an average decrease of 8.8% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 129.2 Cr → 96.7 Cr (in ₹), with an average decrease of 25.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, LALPATHLAB stock has moved down by -0.5%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 53.92% to 53.91% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 6.04% to 5.82% in Dec 2024 quarter

Dr Lal Pathlabs Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹538.90Cr (-)₹545.40Cr (↑1.21%)₹601.90Cr (↑10.36%)₹660.20Cr (↑9.69%)₹596.70Cr (↓9.62%)
Net Income₹82.20Cr (-)₹85.80Cr (↑4.38%)₹107.80Cr (↑25.64%)₹130.80Cr (↑21.34%)₹98.10Cr (↓25.00%)
Net Profit Margin15.25% (-)15.73% (↑3.15%)17.91% (↑13.86%)19.81% (↑10.61%)16.44% (↓17.01%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,574.03Cr (-)₹2,211.72Cr (↑40.51%)₹2,322.20Cr (↑5.00%)₹2,416.63Cr (↑4.07%)
Total Liabilities₹356.94Cr (-)₹739.60Cr (↑107.21%)₹632.33Cr (↓14.50%)₹516.97Cr (↓18.24%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹271.99Cr (-)₹373.36Cr (↑37.27%)₹425.73Cr (↑14.03%)₹427.53Cr (↑0.42%)₹477.60Cr (↑11.71%)

Dr Lal Pathlabs Ltd Index Inclusions

Nifty 500

₹21,339.55

-0.32 (-68.4%)

S&P BSE 250 SmallCap

₹6,039.25

-0.45 (-27.45%)

BSE Healthcare

₹41,421.50

-0.12 (-48.19%)

Nifty MidSmallcap 400

₹17,677.95

-0.2 (-36.15%)

S&P BSE SmallCap Select

₹6,954.89

0.04 (2.86%)

BSE 500

₹33,579.22

-0.39 (-132.39%)

Nifty Small 100

₹16,095.70

-0.15 (-24.15%)

S&P BSE 400 MidSmallCap

₹10,772.07

-0.52 (-56.71%)

Nifty Smallcap 50

₹7,724.65

-0.15 (-11.25%)

Nifty Smallcap 250

₹15,104.05

-0.05 (-7.6%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹46,638.13

-0.35 (-165.52%)

Dr Lal Pathlabs Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
53.91%
-0.02
Foreign Institutions
26.82%
-0.01
Mutual Funds
10.25%
4.14
Retail Investors
5.82%
-3.57
Others
3.21%
-5.30

Dr Lal Pathlabs Ltd Key Indicators

Details20202021202220232024
Return On Equity %22.9225.0825.6818.4921.42
Details20202021202220232024
Return On Assets %17.1318.5315.5910.2914.8
Details20202021202220232024
Book Value Per Share (₹)126.81149.39180.17199.87221.53
Details20202021202220232024
Earning Per Share (₹)27.3135.5742.0328.9243.4

Dr Lal Pathlabs Ltd Valuation

Dr Lal Pathlabs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (37.51x)

November 16, 2018

Today (49.54x)

March 28, 2025

Industry (98.78x)

March 28, 2025

Highest (95.62x)

November 5, 2020

LowHigh

Dr Lal Pathlabs Ltd Earnings and Dividends

  • Dr Lal Pathlabs Ltd Earnings Results

    Dr Lal Pathlabs Ltd’s net profit jumped 18.94% since last year same period to ₹96.70Cr in the Q3 2024-2025. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated -25.15% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Dr Lal Pathlabs Ltd Dividends January,2025

    In the quarter ending December 2024, Dr Lal Pathlabs Ltd has declared dividend of ₹6 - translating a dividend yield of 1.45%.

    Read More about Dividends

Dr Lal Pathlabs Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Dr Lal Pathlabs Ltd is currently in a Bearish trading position according to technical analysis indicators.

Dr Lal Pathlabs Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
HOLD₹20,720.72 Cr14.8%0.55₹362 Cr₹2,226 Cr
HOLD₹33,077.75 Cr171.87%0.67₹168 Cr₹5,040 Cr
HOLD₹58,368.05 Cr21.79%0.56₹1,811 Cr₹12,667 Cr
BUY₹10,337.53 Cr12.49%0.64₹119 Cr₹547 Cr
BUY₹3,601.70 Cr7.18%0.54₹69 Cr₹571 Cr

About Dr Lal Pathlabs Ltd

Dr Lal PathLabs Ltd is a leading diagnostic laboratory chain in India, incorporated in 1949. The company operates in the medical diagnostics business and provides a wide range of services and products, including clinical laboratory services, radiology services, and preventive health check-up packages.

The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.

Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).

Revenue: ₹596.70Cr as on December 2024 (Q4 24)
Net Profit: ₹98.10Cr as on December 2024 (Q4 24)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
OrganisationDr Lal Pathlabs Ltd
HeadquartersGurgaon
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs on Dr Lal Pathlabs Ltd

What is Dr Lal Pathlabs Ltd price today?

Dr Lal Pathlabs Ltd share price today stands at ₹2478.8, Open: ₹2487.75, Previous Close: ₹2488, High: ₹2505, Low: ₹2460, 52 Week High: ₹3653.95, 52 Week Low: ₹2146.

How to Buy Dr Lal Pathlabs Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Dr Lal Pathlabs Ltd shares

What are today's traded volumes of Dr Lal Pathlabs Ltd?

Today's traded volume of Dr Lal Pathlabs Ltd(LALPATHLAB) is 87.65K.

What is today's market capitalisation of Dr Lal Pathlabs Ltd?

Today's market capitalisation of Dr Lal Pathlabs Ltd(LALPATHLAB) is ₹20720.72Cr.

What is the 52 Week High and Low Range of Dr Lal Pathlabs Ltd?

Dr Lal Pathlabs Ltd (LALPATHLAB)
Price
52 Week High
₹3653.95
52 Week Low
₹2146

How much percentage Dr Lal Pathlabs Ltd is down from its 52 Week High?

Dr Lal Pathlabs Ltd (LALPATHLAB) share price is ₹2478.8. It is down -32.16% from its 52 Week High price of ₹3653.95

How much percentage Dr Lal Pathlabs Ltd is up from its 52 Week low?

Dr Lal Pathlabs Ltd (LALPATHLAB) share price is ₹2478.8. It is up 15.51% from its 52 Week Low price of ₹2146